Clinical and biological distinctions between type I and type II acquired angioedema

Am J Med. 2003 Oct 1;115(5):420-1. doi: 10.1016/s0002-9343(03)00396-6.
No abstract available

Publication types

  • Letter

MeSH terms

  • Angioedema / classification*
  • Angioedema / diagnosis
  • Angioedema / drug therapy
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Autoantibodies
  • Complement C1 Inactivator Proteins / deficiency*
  • Complement C1 Inactivator Proteins / immunology
  • Danazol / therapeutic use
  • Humans
  • Male
  • Middle Aged
  • Tranexamic Acid / therapeutic use

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Autoantibodies
  • Complement C1 Inactivator Proteins
  • Tranexamic Acid
  • Danazol